Laura Martinez-Gili
Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites
Martinez-Gili, Laura; McDonald, Julie A.K.; Liu, Zhigang; Kao, Dina; Allegretti, Jessica R.; Monaghan, Tanya M.; Barker, Grace F.; Migu�ns Blanco, Jes�s; Williams, Horace R.T.; Holmes, Elaine; Thursz, Mark R.; Marchesi, Julian R.; Mullish, Benjamin H.
Authors
Julie A.K. McDonald
Zhigang Liu
Dina Kao
Jessica R. Allegretti
TANYA MONAGHAN Tanya.Monaghan@nottingham.ac.uk
Clinical Associate Professor in Luminal Gastroenterology
Grace F. Barker
Jes�s Migu�ns Blanco
Horace R.T. Williams
Elaine Holmes
Mark R. Thursz
Julian R. Marchesi
Benjamin H. Mullish
Abstract
Fecal microbiota transplant (FMT) is a highly-effective therapy for recurrent Clostridioides difficile infection (rCDI), and shows promise for certain non-CDI indications. However, at present, its mechanisms of efficacy have remained poorly understood. Recent studies by our laboratory have noted the particular key importance of restoration of gut microbe-metabolite interactions in the ability of FMT to treat rCDI, including the impact of FMT upon short chain fatty acid (SCFAs) and bile acid metabolism. This includes a significant impact of these metabolites upon the life cycle of C. difficile directly, along with potential postulated additional benefits, including effects upon host immune response. In this Addendum, we first present an overview of these recent advancements in this field, and then describe additional novel data from our laboratory on the impact of FMT for rCDI upon several gut microbial-derived metabolites which had not previously been implicated as being of relevance.
Citation
Martinez-Gili, L., McDonald, J. A., Liu, Z., Kao, D., Allegretti, J. R., Monaghan, T. M., …Mullish, B. H. (2020). Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites. Gut Microbes, 12(1), Article 1810531. https://doi.org/10.1136/gutjnl-2018-317842
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 3, 2020 |
Online Publication Date | Sep 6, 2020 |
Publication Date | Sep 6, 2020 |
Deposit Date | Aug 12, 2020 |
Publicly Available Date | Sep 7, 2021 |
Journal | Gut Microbes |
Print ISSN | 1949-0976 |
Electronic ISSN | 1949-0984 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Volume | 12 |
Issue | 1 |
Article Number | 1810531 |
DOI | https://doi.org/10.1136/gutjnl-2018-317842 |
Keywords | gut microbiome; metabonomics; fecal microbiota transplant; Clostridioides difficile infection; bile acids; short chain fatty acids; trimethylamine |
Public URL | https://nottingham-repository.worktribe.com/output/4828231 |
Publisher URL | https://www.tandfonline.com/doi/full/10.1080/19490976.2020.1810531 |
Files
Figure3 Gut Microbes Addendum Resubmission.pdf
(81 Kb)
PDF
Figure2 Gut Microbes Addendum Resubmission
(91 Kb)
PDF
Figure1 Gut Microbes Addendum Resubmission
(29 Kb)
PDF
Supplementary Gut Microbes Addendum 1stresubmission
(1.2 Mb)
PDF
Understanding the mechanisms of efficacy
(1.7 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
New perspectives in Clostridium difficile disease pathogenesis
(2015)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search